De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Beauty Health Toekomstige groei
Future criteriumcontroles 0/6
De verwachting is dat Beauty Health de winst en omzet met respectievelijk 85.4% en 5.1% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 86.6% per jaar.
Belangrijke informatie
85.4%
Groei van de winst
86.6%
Groei van de winst per aandeel
| Personal Products winstgroei | 23.3% |
| Inkomstengroei | 5.1% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 24 Sep 2024 |
Recente toekomstige groei-updates
Recent updates
Health Check: How Prudently Does Beauty Health (NASDAQ:SKIN) Use Debt?
Oct 18
Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump
Aug 06Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?
Jul 16Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%
Jun 14Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)
May 30The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company
Feb 16The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion
Jun 19Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?
May 28At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?
Apr 04Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality
Mar 08What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?
Jan 01An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued
Dec 05The Beauty Health Company: A Compelling Mid To Long-Term Growth Story
Oct 12Beauty-Health Company announces $200M buyback program
Sep 27The Beauty Health Q2 2022 Earnings Preview
Aug 08The Beauty Health Company: Not Looking The Best
Jul 30Beauty Health: Skincare Today And Alpha Tomorrow
May 13Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates
May 12Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 404 | 2 | -11 | -18 | 4 |
| 12/31/2025 | 378 | -26 | 15 | 22 | 11 |
| 12/31/2024 | 341 | -29 | -29 | -24 | 10 |
| 6/30/2024 | 366 | -84 | -8 | 2 | N/A |
| 3/31/2024 | 393 | -81 | 6 | 18 | N/A |
| 12/31/2023 | 398 | -100 | -10 | 22 | N/A |
| 9/30/2023 | 399 | -84 | -11 | 22 | N/A |
| 6/30/2023 | 391 | -10 | -63 | -28 | N/A |
| 3/31/2023 | 377 | -7 | -118 | -81 | N/A |
| 12/31/2022 | 366 | 44 | -125 | -107 | N/A |
| 9/30/2022 | 346 | 20 | -123 | -98 | N/A |
| 6/30/2022 | 325 | -195 | -85 | -66 | N/A |
| 3/31/2022 | 288 | -340 | -86 | -68 | N/A |
| 12/31/2021 | 260 | -379 | -44 | -28 | N/A |
| 9/30/2021 | 220 | -365 | -40 | -32 | N/A |
| 6/30/2021 | 186 | -152 | -40 | -33 | N/A |
| 3/31/2021 | 134 | -23 | N/A | N/A | N/A |
| 12/31/2020 | 119 | -29 | -16 | -12 | N/A |
| 9/30/2020 | 131 | -19 | -12 | -3 | N/A |
| 12/31/2019 | 167 | -2 | -9 | 2 | N/A |
| 12/31/2018 | 112 | -91 | -9 | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat SKIN de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat SKIN de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat SKIN de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van SKIN ( 5.1% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.7% per jaar).
Hoge groei-inkomsten: De omzet van SKIN ( 5.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van SKIN naar verwachting over 3 jaar hoog zal zijn